Bourgeon Capital Management’s AbbVie ABBV Stock Holding History

Bourgeon Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$765K	Buy	3,519 +12	+0.3%	+$2.66K	0.13%	61
2025 Q4	$801K	Buy	+3,507	New	+$799K	0.13%	67
2024 Q1	–	Sell	-340	Closed	-$52.7K	–	114
2023 Q4	$52.7K	Buy	340 +240	+240%	+$35K	0.01%	149
2023 Q3	$14.9K	Hold	100	–	–	﹤0.01%	214
2023 Q2	$13.5K	Hold	100	–	–	﹤0.01%	234
2023 Q1	$15.9K	Hold	100	–	–	﹤0.01%	206
2022 Q4	$16.2K	Buy	+100	New	+$15.3K	﹤0.01%	208

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bourgeon Capital Management's ABBV Position: Q1 2026 in Review

Bourgeon Capital Management increased its AbbVie (ABBV) stake by 0.34% in Q1 2026, buying an estimated $2.66K and bringing the position to 3,519 shares worth $765K. The position accounts for 0.13% of the portfolio, ranked #61.

Bourgeon Capital Management first reported a position in ABBV in Q4 2022 and has held it in 7 quarters since. The position peaked at $801K in Q4 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Bourgeon Capital Management held 3,519 shares of AbbVie worth $765K as of Q1 2026.
Bourgeon Capital Management bought 12 AbbVie shares in Q1 2026, an estimated $2.66K.
AbbVie made up 0.13% of Bourgeon Capital Management's portfolio in Q1 2026, its #61 holding.
Bourgeon Capital Management first reported a position in AbbVie in Q4 2022 and has held it in 7 quarters since.
Bourgeon Capital Management's AbbVie position peaked at $801K in Q4 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bourgeon Capital Management's 13F filing for Q1 2026, filed 13 Apr 2026.